UTI or Yeast Infection on a GLP-1: What to Do This Week

The short version

If you have urinary or vaginal symptoms and you take a GLP-1, the fastest useful thing you can know is this: it is probably not the GLP-1, and there is one question that changes the answer — do you also take an SGLT2 inhibitor?

Everything below is the ten-minute version. Educational only, not medical advice.

The label table

I read the current prescribing information for all five products rather than working from memory. This is the whole picture on one screen:

Across all four GLP-1 and dual-agonist labels there is exactly one urinary tract infection entry and zero mentions of candidiasis, vaginal infection or genital mycotic infection. The SGLT2 inhibitor has a warnings section for precisely this.

The reason is mechanical: SGLT2 inhibitors work by pushing glucose out through your urine, and yeast feeds on it. GLP-1s do not do that. There is population-based work on SGLT2 inhibitors and severe urinary tract infections in that same literature⁶.

The one question that changes the answer

Do you also take an SGLT2 inhibitor? The common ones end in -flozin: empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana), ertugliflozin (Steglatro).

Combination therapy with a GLP-1 and an SGLT2 inhibitor is routine in type 2 diabetes. If both are in your cabinet, the genital-infection risk is real and it belongs to the other prescription. That single fact reorganises the whole conversation, and it is the thing most likely to get missed if you only mention the drug you started most recently.

Also worth knowing regardless of medication: women with type 2 diabetes have higher rates of vaginal candida colonisation and symptoms independent of any drug⁷. Glycaemic control is part of the picture before you add anything.

The decision list

Go same-day, not next week, if: you have fever, back or flank pain, blood in your urine, vomiting, or you are pregnant. Those are the signs that a urinary infection may be moving upward, and it is not a wait-and-see situation.

Book normally if: it is burning, urgency or frequency without the above; or vaginal itching or discharge without fever. Get it tested rather than guessing — the treatments are different and a wrong guess wastes a week.

Do not assume it is the GLP-1 and stop the medication to see what happens. Nothing on the label supports that, and you will have lost your titration progress for no reason.

Do not self-treat a suspected first yeast infection over the counter if you also take an SGLT2 inhibitor and this keeps happening — recurrence is a reason for a proper workup, not a bigger box of antifungal.

Using a 12-minute appointment

The appointment is short. These are the four sentences that make it productive:

1. 1."I take [GLP-1] and [any SGLT2 inhibitor]." Lead with both. If you take an -flozin, that is the single most relevant thing you will say.
2. 2."This is the Nth time in M months." Recurrence changes the plan; a single episode usually does not.
3. 3."My last A1c was X" — or "I do not know it." Either answer is useful.
4. 4."Can we test rather than treat empirically?" Especially for a second or third episode.

If it is dryness or irritation rather than infection, that is a different conversation and the evidence in that area genuinely runs out — say "dryness, not itching or discharge," because it points somewhere else entirely.

Where the provider you chose comes in

Two things matter here and both are provider-selection questions: whether you can get a message answered in a day when something like this comes up mid-titration, and whether the intake actually asked what else you take. A program that never asked about your other prescriptions is not in a position to help you reason about this.

See also the side-effect quick-fix reference and, for the belching version of "is this the drug", burping by drug.